PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.06%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$205M
AUM Growth
+$205M
(-1.1%)
Cap. Flow
-$6.74M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
44.35%
Holding
98
New
19
Increased
15
Reduced
9
Closed
26
Top Buys
| 1 |
Dentsply Sirona
XRAY
|
$9.57M |
| 2 |
Centene
CNC
|
$7.74M |
| 3 |
AGN
Allergan plc
AGN
|
$7.17M |
| 4 |
DexCom
DXCM
|
$5.87M |
| 5 |
Incyte
INCY
|
$5.84M |
Top Sells
| 1 |
Labcorp
LH
|
$10M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.01M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$6.55M |
| 4 |
NXTM
NxStage Medical Inc.
NXTM
|
$5.56M |
| 5 |
QGENF
QIAGEN NV
QGENF
|
$5.26M |
Sector Composition
| 1 | Healthcare | 83.18% |
| 2 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boston Scientific
BSX
$156B
| $11.4M | 3.33% | 390,000 -30,546 | -7% | -$891K |
|
2
LivaNova
LIVN
$3.08B
| $10.8M | 3.16% | 154,273 +14,271 | +10% | +$1,000K |
|
3
ICU Medical
ICUI
$3.15B
| $10.7M | 3.13% | 57,500 +12,500 | +28% | +$2.32M |
|
4
Merck
MRK
$210B
| $9.9M | 2.9% | 154,570 +24,570 | +19% | +$1.57M |
|
|
5
Dentsply Sirona
XRAY
$2.85B
| $9.57M | 2.8% | +160,000 | New | +$9.57M |
|
6
Baxter International
BAX
$12.7B
| $8.47M | 2.48% | 135,000 +10,000 | +8% | +$627K |
|
|
IVC
7
DELISTED
Invacare Corporation
IVC
| $7.88M | 2.3% | 500,000 -5,000 | -1% | -$78.8K |
|
|
8
Centene
CNC
$14.3B
| $7.74M | 2.27% | +80,000 | New | +$7.74M |
|
|
ATHN
9
DELISTED
Athenahealth, Inc.
ATHN
| $7.44M | 2.18% | 59,800 +16,800 | +39% | +$2.09M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $7.17M | 2.1% | +35,000 | New | +$7.17M |
|
|
ESRX
11
DELISTED
Express Scripts Holding Company
ESRX
| $6.33M | 1.85% | 100,000 -74,700 | -43% | -$4.73M |
|
|
XENT
12
DELISTED
Intersect ENT, Inc
XENT
| $6.23M | 1.82% | 200,000 +2,502 | +1% | +$77.9K |
|
13
Bio-Rad Laboratories Class A
BIO
$8.06B
| $6.22M | 1.82% | 28,000 +5,180 | +23% | +$1.15M |
|
|
14
DexCom
DXCM
$29.5B
| $5.87M | 1.72% | +120,000 | New | +$5.87M |
|
|
15
Incyte
INCY
$16.5B
| $5.84M | 1.71% | +50,000 | New | +$5.84M |
|
|
EVHC
16
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $5.54M | 1.62% | 123,192 -64,008 | -34% | -$2.88M |
|
17
Penumbra
PEN
$10.6B
| $5.38M | 1.57% | 59,579 +9,579 | +19% | +$865K |
|
18
QuidelOrtho
QDEL
$1.95B
| $4.83M | 1.41% | +110,000 | New | +$4.83M |
|
19
Vertex Pharmaceuticals
VRTX
$100B
| $4.55M | 1.33% | +29,900 | New | +$4.55M |
|
|
NSTG
20
DELISTED
NanoString Technologies, Inc.
NSTG
| $4.44M | 1.3% | 275,000 -123,206 | -31% | -$1.99M |
|
21
Axogen
AXGN
$743M
| $4.44M | 1.3% | 229,278 +49,909 | +28% | +$966K |
|
22
Abbott
ABT
$231B
| $4.27M | 1.25% | +80,000 | New | +$4.27M |
|
23
Globus Medical
GMED
$8.27B
| $3.84M | 1.12% | 129,074 -70,926 | -35% | -$2.11M |
|
|
VRAY
24
DELISTED
ViewRay, Inc.
VRAY
| $3.5M | 1.02% | 607,040 +346,370 | +133% | +$2M |
|
|
NBRV
25
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $3.48M | 1.02% | +425,000 | New | +$3.48M |
|